0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global De Novo Sequencing Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-17G13357
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global De Novo Sequencing Market Research Report 2023
BUY CHAPTERS

Global De Novo Sequencing Market Research Report 2024

Code: QYRE-Auto-17G13357
Report
August 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

De Novo Sequencing Market

The global De Novo Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for De Novo Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for De Novo Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for De Novo Sequencing in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of De Novo Sequencing include 10X Genomics Inc., Abcam Plc, Exeter Clinical Laboratory, Psomagen, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG and Eurofins Scientific SE, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for De Novo Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding De Novo Sequencing.

Report Scope

The De Novo Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global De Novo Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the De Novo Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of De Novo Sequencing Market Report

Report Metric Details
Report Name De Novo Sequencing Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 10X Genomics Inc., Abcam Plc, Exeter Clinical Laboratory, Psomagen, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., CD Genomics, Illumina, qGenomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of De Novo Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the De Novo Sequencing Market report?

Ans: The main players in the De Novo Sequencing Market are 10X Genomics Inc., Abcam Plc, Exeter Clinical Laboratory, Psomagen, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., CD Genomics, Illumina, qGenomics

What are the Application segmentation covered in the De Novo Sequencing Market report?

Ans: The Applications covered in the De Novo Sequencing Market report are Oncology, Hereditary Disease Detection, Life Science

What are the Type segmentation covered in the De Novo Sequencing Market report?

Ans: The Types covered in the De Novo Sequencing Market report are Genome Survey, Gene Annotation, Evolution Analysis, Auxiliary Assembly

Recommended Reports

Sequencing Equipment

Sequencing Services

Genomic Data Analysis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global De Novo Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genome Survey
1.2.3 Gene Annotation
1.2.4 Evolution Analysis
1.2.5 Auxiliary Assembly
1.3 Market by Application
1.3.1 Global De Novo Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Hereditary Disease Detection
1.3.4 Life Science
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global De Novo Sequencing Market Perspective (2019-2030)
2.2 De Novo Sequencing Growth Trends by Region
2.2.1 Global De Novo Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 De Novo Sequencing Historic Market Size by Region (2019-2024)
2.2.3 De Novo Sequencing Forecasted Market Size by Region (2025-2030)
2.3 De Novo Sequencing Market Dynamics
2.3.1 De Novo Sequencing Industry Trends
2.3.2 De Novo Sequencing Market Drivers
2.3.3 De Novo Sequencing Market Challenges
2.3.4 De Novo Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top De Novo Sequencing Players by Revenue
3.1.1 Global Top De Novo Sequencing Players by Revenue (2019-2024)
3.1.2 Global De Novo Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global De Novo Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by De Novo Sequencing Revenue
3.4 Global De Novo Sequencing Market Concentration Ratio
3.4.1 Global De Novo Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by De Novo Sequencing Revenue in 2023
3.5 De Novo Sequencing Key Players Head office and Area Served
3.6 Key Players De Novo Sequencing Product Solution and Service
3.7 Date of Enter into De Novo Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 De Novo Sequencing Breakdown Data by Type
4.1 Global De Novo Sequencing Historic Market Size by Type (2019-2024)
4.2 Global De Novo Sequencing Forecasted Market Size by Type (2025-2030)
5 De Novo Sequencing Breakdown Data by Application
5.1 Global De Novo Sequencing Historic Market Size by Application (2019-2024)
5.2 Global De Novo Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America De Novo Sequencing Market Size (2019-2030)
6.2 North America De Novo Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America De Novo Sequencing Market Size by Country (2019-2024)
6.4 North America De Novo Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe De Novo Sequencing Market Size (2019-2030)
7.2 Europe De Novo Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe De Novo Sequencing Market Size by Country (2019-2024)
7.4 Europe De Novo Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific De Novo Sequencing Market Size (2019-2030)
8.2 Asia-Pacific De Novo Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific De Novo Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific De Novo Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America De Novo Sequencing Market Size (2019-2030)
9.2 Latin America De Novo Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America De Novo Sequencing Market Size by Country (2019-2024)
9.4 Latin America De Novo Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa De Novo Sequencing Market Size (2019-2030)
10.2 Middle East & Africa De Novo Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa De Novo Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa De Novo Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10X Genomics Inc.
11.1.1 10X Genomics Inc. Company Detail
11.1.2 10X Genomics Inc. Business Overview
11.1.3 10X Genomics Inc. De Novo Sequencing Introduction
11.1.4 10X Genomics Inc. Revenue in De Novo Sequencing Business (2019-2024)
11.1.5 10X Genomics Inc. Recent Development
11.2 Abcam Plc
11.2.1 Abcam Plc Company Detail
11.2.2 Abcam Plc Business Overview
11.2.3 Abcam Plc De Novo Sequencing Introduction
11.2.4 Abcam Plc Revenue in De Novo Sequencing Business (2019-2024)
11.2.5 Abcam Plc Recent Development
11.3 Exeter Clinical Laboratory
11.3.1 Exeter Clinical Laboratory Company Detail
11.3.2 Exeter Clinical Laboratory Business Overview
11.3.3 Exeter Clinical Laboratory De Novo Sequencing Introduction
11.3.4 Exeter Clinical Laboratory Revenue in De Novo Sequencing Business (2019-2024)
11.3.5 Exeter Clinical Laboratory Recent Development
11.4 Psomagen
11.4.1 Psomagen Company Detail
11.4.2 Psomagen Business Overview
11.4.3 Psomagen De Novo Sequencing Introduction
11.4.4 Psomagen Revenue in De Novo Sequencing Business (2019-2024)
11.4.5 Psomagen Recent Development
11.5 BGI Genomics Co. Ltd.
11.5.1 BGI Genomics Co. Ltd. Company Detail
11.5.2 BGI Genomics Co. Ltd. Business Overview
11.5.3 BGI Genomics Co. Ltd. De Novo Sequencing Introduction
11.5.4 BGI Genomics Co. Ltd. Revenue in De Novo Sequencing Business (2019-2024)
11.5.5 BGI Genomics Co. Ltd. Recent Development
11.6 Bio Rad Laboratories Inc.
11.6.1 Bio Rad Laboratories Inc. Company Detail
11.6.2 Bio Rad Laboratories Inc. Business Overview
11.6.3 Bio Rad Laboratories Inc. De Novo Sequencing Introduction
11.6.4 Bio Rad Laboratories Inc. Revenue in De Novo Sequencing Business (2019-2024)
11.6.5 Bio Rad Laboratories Inc. Recent Development
11.7 Danaher Corp.
11.7.1 Danaher Corp. Company Detail
11.7.2 Danaher Corp. Business Overview
11.7.3 Danaher Corp. De Novo Sequencing Introduction
11.7.4 Danaher Corp. Revenue in De Novo Sequencing Business (2019-2024)
11.7.5 Danaher Corp. Recent Development
11.8 Eppendorf AG
11.8.1 Eppendorf AG Company Detail
11.8.2 Eppendorf AG Business Overview
11.8.3 Eppendorf AG De Novo Sequencing Introduction
11.8.4 Eppendorf AG Revenue in De Novo Sequencing Business (2019-2024)
11.8.5 Eppendorf AG Recent Development
11.9 Eurofins Scientific SE
11.9.1 Eurofins Scientific SE Company Detail
11.9.2 Eurofins Scientific SE Business Overview
11.9.3 Eurofins Scientific SE De Novo Sequencing Introduction
11.9.4 Eurofins Scientific SE Revenue in De Novo Sequencing Business (2019-2024)
11.9.5 Eurofins Scientific SE Recent Development
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Company Detail
11.10.2 F. Hoffmann-La Roche Ltd. Business Overview
11.10.3 F. Hoffmann-La Roche Ltd. De Novo Sequencing Introduction
11.10.4 F. Hoffmann-La Roche Ltd. Revenue in De Novo Sequencing Business (2019-2024)
11.10.5 F. Hoffmann-La Roche Ltd. Recent Development
11.11 CD Genomics
11.11.1 CD Genomics Company Detail
11.11.2 CD Genomics Business Overview
11.11.3 CD Genomics De Novo Sequencing Introduction
11.11.4 CD Genomics Revenue in De Novo Sequencing Business (2019-2024)
11.11.5 CD Genomics Recent Development
11.12 Illumina
11.12.1 Illumina Company Detail
11.12.2 Illumina Business Overview
11.12.3 Illumina De Novo Sequencing Introduction
11.12.4 Illumina Revenue in De Novo Sequencing Business (2019-2024)
11.12.5 Illumina Recent Development
11.13 qGenomics
11.13.1 qGenomics Company Detail
11.13.2 qGenomics Business Overview
11.13.3 qGenomics De Novo Sequencing Introduction
11.13.4 qGenomics Revenue in De Novo Sequencing Business (2019-2024)
11.13.5 qGenomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global De Novo Sequencing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Genome Survey
    Table 3. Key Players of Gene Annotation
    Table 4. Key Players of Evolution Analysis
    Table 5. Key Players of Auxiliary Assembly
    Table 6. Global De Novo Sequencing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global De Novo Sequencing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global De Novo Sequencing Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global De Novo Sequencing Market Share by Region (2019-2024)
    Table 10. Global De Novo Sequencing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global De Novo Sequencing Market Share by Region (2025-2030)
    Table 12. De Novo Sequencing Market Trends
    Table 13. De Novo Sequencing Market Drivers
    Table 14. De Novo Sequencing Market Challenges
    Table 15. De Novo Sequencing Market Restraints
    Table 16. Global De Novo Sequencing Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global De Novo Sequencing Market Share by Players (2019-2024)
    Table 18. Global Top De Novo Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in De Novo Sequencing as of 2023)
    Table 19. Ranking of Global Top De Novo Sequencing Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by De Novo Sequencing Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players De Novo Sequencing Product Solution and Service
    Table 23. Date of Enter into De Novo Sequencing Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global De Novo Sequencing Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global De Novo Sequencing Revenue Market Share by Type (2019-2024)
    Table 27. Global De Novo Sequencing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global De Novo Sequencing Revenue Market Share by Type (2025-2030)
    Table 29. Global De Novo Sequencing Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global De Novo Sequencing Revenue Market Share by Application (2019-2024)
    Table 31. Global De Novo Sequencing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global De Novo Sequencing Revenue Market Share by Application (2025-2030)
    Table 33. North America De Novo Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America De Novo Sequencing Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America De Novo Sequencing Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe De Novo Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe De Novo Sequencing Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe De Novo Sequencing Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific De Novo Sequencing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific De Novo Sequencing Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific De Novo Sequencing Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America De Novo Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America De Novo Sequencing Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America De Novo Sequencing Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa De Novo Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa De Novo Sequencing Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa De Novo Sequencing Market Size by Country (2025-2030) & (US$ Million)
    Table 48. 10X Genomics Inc. Company Detail
    Table 49. 10X Genomics Inc. Business Overview
    Table 50. 10X Genomics Inc. De Novo Sequencing Product
    Table 51. 10X Genomics Inc. Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 52. 10X Genomics Inc. Recent Development
    Table 53. Abcam Plc Company Detail
    Table 54. Abcam Plc Business Overview
    Table 55. Abcam Plc De Novo Sequencing Product
    Table 56. Abcam Plc Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 57. Abcam Plc Recent Development
    Table 58. Exeter Clinical Laboratory Company Detail
    Table 59. Exeter Clinical Laboratory Business Overview
    Table 60. Exeter Clinical Laboratory De Novo Sequencing Product
    Table 61. Exeter Clinical Laboratory Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 62. Exeter Clinical Laboratory Recent Development
    Table 63. Psomagen Company Detail
    Table 64. Psomagen Business Overview
    Table 65. Psomagen De Novo Sequencing Product
    Table 66. Psomagen Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 67. Psomagen Recent Development
    Table 68. BGI Genomics Co. Ltd. Company Detail
    Table 69. BGI Genomics Co. Ltd. Business Overview
    Table 70. BGI Genomics Co. Ltd. De Novo Sequencing Product
    Table 71. BGI Genomics Co. Ltd. Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 72. BGI Genomics Co. Ltd. Recent Development
    Table 73. Bio Rad Laboratories Inc. Company Detail
    Table 74. Bio Rad Laboratories Inc. Business Overview
    Table 75. Bio Rad Laboratories Inc. De Novo Sequencing Product
    Table 76. Bio Rad Laboratories Inc. Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 77. Bio Rad Laboratories Inc. Recent Development
    Table 78. Danaher Corp. Company Detail
    Table 79. Danaher Corp. Business Overview
    Table 80. Danaher Corp. De Novo Sequencing Product
    Table 81. Danaher Corp. Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 82. Danaher Corp. Recent Development
    Table 83. Eppendorf AG Company Detail
    Table 84. Eppendorf AG Business Overview
    Table 85. Eppendorf AG De Novo Sequencing Product
    Table 86. Eppendorf AG Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 87. Eppendorf AG Recent Development
    Table 88. Eurofins Scientific SE Company Detail
    Table 89. Eurofins Scientific SE Business Overview
    Table 90. Eurofins Scientific SE De Novo Sequencing Product
    Table 91. Eurofins Scientific SE Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 92. Eurofins Scientific SE Recent Development
    Table 93. F. Hoffmann-La Roche Ltd. Company Detail
    Table 94. F. Hoffmann-La Roche Ltd. Business Overview
    Table 95. F. Hoffmann-La Roche Ltd. De Novo Sequencing Product
    Table 96. F. Hoffmann-La Roche Ltd. Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 97. F. Hoffmann-La Roche Ltd. Recent Development
    Table 98. CD Genomics Company Detail
    Table 99. CD Genomics Business Overview
    Table 100. CD Genomics De Novo Sequencing Product
    Table 101. CD Genomics Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 102. CD Genomics Recent Development
    Table 103. Illumina Company Detail
    Table 104. Illumina Business Overview
    Table 105. Illumina De Novo Sequencing Product
    Table 106. Illumina Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 107. Illumina Recent Development
    Table 108. qGenomics Company Detail
    Table 109. qGenomics Business Overview
    Table 110. qGenomics De Novo Sequencing Product
    Table 111. qGenomics Revenue in De Novo Sequencing Business (2019-2024) & (US$ Million)
    Table 112. qGenomics Recent Development
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global De Novo Sequencing Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global De Novo Sequencing Market Share by Type: 2023 VS 2030
    Figure 3. Genome Survey Features
    Figure 4. Gene Annotation Features
    Figure 5. Evolution Analysis Features
    Figure 6. Auxiliary Assembly Features
    Figure 7. Global De Novo Sequencing Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global De Novo Sequencing Market Share by Application: 2023 VS 2030
    Figure 9. Oncology Case Studies
    Figure 10. Hereditary Disease Detection Case Studies
    Figure 11. Life Science Case Studies
    Figure 12. De Novo Sequencing Report Years Considered
    Figure 13. Global De Novo Sequencing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global De Novo Sequencing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global De Novo Sequencing Market Share by Region: 2023 VS 2030
    Figure 16. Global De Novo Sequencing Market Share by Players in 2023
    Figure 17. Global Top De Novo Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in De Novo Sequencing as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by De Novo Sequencing Revenue in 2023
    Figure 19. North America De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America De Novo Sequencing Market Share by Country (2019-2030)
    Figure 21. United States De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe De Novo Sequencing Market Share by Country (2019-2030)
    Figure 25. Germany De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific De Novo Sequencing Market Share by Region (2019-2030)
    Figure 33. China De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America De Novo Sequencing Market Share by Country (2019-2030)
    Figure 41. Mexico De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa De Novo Sequencing Market Share by Country (2019-2030)
    Figure 45. Turkey De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia De Novo Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. 10X Genomics Inc. Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 48. Abcam Plc Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 49. Exeter Clinical Laboratory Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 50. Psomagen Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 51. BGI Genomics Co. Ltd. Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 52. Bio Rad Laboratories Inc. Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 53. Danaher Corp. Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 54. Eppendorf AG Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 55. Eurofins Scientific SE Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 56. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 57. CD Genomics Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 58. Illumina Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 59. qGenomics Revenue Growth Rate in De Novo Sequencing Business (2019-2024)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart